Hematological Cancer News
Top Stories
Scientists Design A Virtual Pregnant Woman To Study Radiation's Effects
POSTED: April 29, 2008Destroying a tumor in a body with radiation poses a number of challenges and risks, especially for a pregnant woman and her fetus. Researchers at Rensselaer Polytechnic Institute are working to reduce those risks by advancing computer techniques that use virtual models of the human body. Their latest research looks at ways to protect a developing...
Egg Breakthrough Could Preserve Fertility
POSTED: April 25, 2008Scientists in Scotland yesterday revealed a major breakthrough in helping to preserve women's fertility. A team from Edinburgh University have succeeded in taking early stage follicles from a woman's ovaries and maturing them into eggs in the lab for the first time. The discovery should help women undergoing cancer treatment, or those wish...
NCCN Updates non-Hodgkin's Lymphoma Guidelines
POSTED: April 22, 2008FORT WASHINGTON, Pa. -- The National Comprehensive Cancer Network (NCCN) announces several new updates to the NCCN Clinical Practice Guidelines in Oncology(TM) Non-Hodgkin's Lymphoma (NHL). These changes highlight leading developments in the treatment of NHL and represent the recognized standard for clinical care in oncology in both the communit...
AACR Presentation Illustrates Broad Potential Of Antisoma's AS1411 In Blood Cancers
POSTED: April 18, 2008LONDON and SAN DIEGO, CA -- Antisoma plc announces that new preclinical data on its anti-nucleolin aptamer drug AS1411 are presented today at the American Association for Cancer Research (AACR) meeting in San Diego, CA. The presentation shows that AS1411 killed cells from a variety of blood cancer cell lines, including leukemias, lymphomas and ...
Milatuzumab May Enhance Efficacies Of Therapeutics For Multiple Myeloma In Preclinical Studies
POSTED: April 15, 2008SAN DIEGO -- Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, announced today that milatuzumab, its humanized anti-CD74 antibody, showed in animal models promising therapeutic activity for multiple myeloma when used alone or in combination with bortezomib and ...
Marrow Stem Cell Gene Is Identified
POSTED: April 15, 2008BOSTON -- U.S. scientists say they have identified a gene responsible for the division and movement of marrow-derived, blood-forming stem cells. The researchers at the Joslin Diabetes Center said their discovery could have major implications for the future of bone marrow and blood cell transplantation. Every year, some 45,000 people undergo ...
Primary Colonic Lymphoma
POSTED: April 15, 2008The gastrointestinal tract is the most frequent site of extranodal lymphoma, representing approximately 6 to 12 per cent of all extranodal lymphomas.1,2 The stomach is the most frequently involved site followed by the small bowel and large bowel, where lymphomas represent 0.2 to 0.4 per cent of all colorectal tumors.3 It is a rare disease. Most of t...
Veltuzumab Enhances Radioimmunotherapy With Epratuzumab In Lymphoma Model
POSTED: April 15, 2008SAN DIEGO -- Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that combining veltuzumab, the Company's proprietary humanized anti-CD20 antibody, with yttrium-90-labeled epratuzumab, its humanized anti-CD22 antibody, improves treatment responses ...
Immunomedics' Pretargeting Method May Improve Radioimmunotherapy Of Cancer
POSTED: April 15, 2008SAN DIEGO -- Immunomedics, Inc, a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that results presented at the 2008 Annual Meeting of AACR in San Diego, CA, demonstrated that pretargeting radioimmunotherapy (RAIT) with a trivalent bispecific monoclonal antibody (b...
Childhood Leukemia Survivors Struggle With Long-term Comorbidities
POSTED: April 15, 2008Survival rates of childhood cancers, especially leukemia, have improved greatly in the past three decades, but survivors of this disease still seem to face many health and lifestyle challenges as young adults. Depending on the extent of their disease and treatment methods, many continue to struggle with one or more life-long medical conditions and decre...
